RTGNOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
RetinalGenix Technologies Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$3.99+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $75.04M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$0.45 (+12.71%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $75.04M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$2.09M
- EPS, diluted
- -$0.11
- Book value per share
- -$0.14
- Diluted shares
- 19M
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Net income
-$2.09M
EPS, diluted
-$0.11
Reported periodTrailing twelve months